IceCure Medical (ICCM) Cash from Operations (QoQ) (2020 - 2026)
IceCure Medical (ICCM) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | IceCure Medical | 7.28 Mn | -831,247.19 | 295,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.90% |
| Dec 31, 2025 | -85.55% |
| Sep 30, 2025 | 3.81% |
| Jun 30, 2025 | 30.36% |
| Mar 31, 2025 | 3.74% |
| Dec 31, 2024 | -33.05% |
| Sep 30, 2024 | -33.43% |
| Jun 30, 2024 | 17.15% |
| Mar 31, 2024 | -23.78% |
| Dec 31, 2023 | 30.98% |
| Sep 30, 2023 | 15.94% |
| Jun 30, 2023 | -35.21% |
| Mar 31, 2023 | 28.85% |
| Dec 31, 2022 | -24.37% |
| Sep 30, 2022 | 12.31% |
| Jun 30, 2022 | -23.69% |
| Mar 31, 2022 | 48.08% |
| Dec 31, 2021 | -87.11% |
| Sep 30, 2021 | -83.35% |
| Jun 30, 2021 | 6.78% |